Arcus Biosciences, Inc.·4

Dec 22, 4:06 PM ET

Azoy Alexander 4

4 · Arcus Biosciences, Inc. · Filed Dec 22, 2023

Insider Transaction Report

Form 4
Period: 2023-12-20
Azoy Alexander
Chief Accounting Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2023-12-20$18.21/sh68$1,23810,220 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2023.

Documents

1 file
  • 4
    wk-form4_1703279185.xmlPrimary

    FORM 4